STARMOUNT LIFE INSURANCE COMPANY – Trademark Portfolio

Entity Type: 03

STARMOUNT LIFE INSURANCE COMPANY holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 13 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include STARMOUNT, ALWAYSCARE, ALWAYSDENTAL, ALWAYSVISION, and PROTECT TOMORROW...BY PLANNING TODAY!. The owner is based in PORTLAND, ME.

2211 CONGRESS STREET

PORTLAND, ME 04122

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

STARMOUNT LIFE INSURANCE COMPANY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (13 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does STARMOUNT LIFE INSURANCE COMPANY have?

STARMOUNT LIFE INSURANCE COMPANY has 13 U.S. trademarks filed with the USPTO. Of these, 6 registered, 7 cancelled.

What trademark classes does STARMOUNT LIFE INSURANCE COMPANY file in?

STARMOUNT LIFE INSURANCE COMPANY files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are STARMOUNT LIFE INSURANCE COMPANY's most well-known trademarks?

STARMOUNT LIFE INSURANCE COMPANY's registered trademark portfolio includes well-known marks such as STARMOUNT, ALWAYSCARE, ALWAYSDENTAL, ALWAYSVISION, and PROTECT TOMORROW...BY PLANNING TODAY!. These are among 6 currently registered trademarks in the portfolio.

What is STARMOUNT LIFE INSURANCE COMPANY's trademark registration success rate?

STARMOUNT LIFE INSURANCE COMPANY has a 46% trademark registration rate, with 6 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.